Urinary Bladder Diseases D001745

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Urinary Bladder Diseases

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urinary Bladder Diseases

Description

Pathological processes of the URINARY BLADDER.   MeSH

Subtype Terms (11)

Bladder Exstrophy
1 experimental drug

Cystitis
28 drugs (22 approved, 6 experimental)

Cystocele
3 approved drugs

Urinary Bladder Calculi
1 approved drug

Urinary Bladder Fistula
 

Urinary Bladder Neck Obstruction
7 drugs (6 approved, 1 experimental)

Urinary Bladder Neoplasms
428 drugs (189 approved, 239 experimental)

Urinary Bladder, Neurogenic
32 drugs (22 approved, 10 experimental)

Urinary Bladder, Overactive
89 drugs (46 approved, 43 experimental)

Urinary Bladder, Underactive
3 drugs (1 approved, 2 experimental)

Vesico-Ureteral Reflux
13 drugs (10 approved, 3 experimental)


Phase 1 Indicated Drugs (4)


Organization Involved with Phase 1 Indications (1)

Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.